Fierce Pharma October 11, 2024
Nick Paul Taylor

A survey of more than 2,000 patients and physicians has painted a rosy picture of the impact of pharma ads, showing that promotions raise awareness of treatment options, drive discovery of health conditions and improve management of existing ailments.

The survey is the result of a collaboration between media intelligence business Magna and advertising platform DeepIntent. Together, the businesses ran online surveys of 1,166 patients and 1,001 doctors to determine whether pharma ads do more than just build brands. Advocates of direct-to-consumer ads argue they have educational value and improve health. The survey gathered data to support that view.

First, Magna and DeepIntent showed pharma ads do their primary job: raising awareness of treatments. Almost two-thirds of patients said they...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Physician, Provider, Survey / Study, Trends
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article